Preventing Ventilator-Associated Pneumonia in the United States: A Multicenter Mixed-Methods Study

2008 ◽  
Vol 29 (10) ◽  
pp. 933-940 ◽  
Author(s):  
Sarah L. Krein ◽  
Christine P. Kowalski ◽  
Laura Damschroder ◽  
Jane Forman ◽  
Samuel R. Kaufman ◽  
...  

Objective.To determine what practices are used by hospitals to prevent ventilator-associated pneumonia (VAP) and, through qualitative methods, to understand more fully why hospitals use certain practices and not others.Design.Mixed-methods, sequential explanatory study.Methods.We mailed a survey to the lead infection control professionals at 719 US hospitals (119 Department of Veterans Affairs [VA] hospitals and 600 non-VA hospitals), to determine what practices are used to prevent VAP. We then selected 14 hospitals for an in-depth qualitative investigation, to ascertain why certain infection control practices are used and others not, interviewing 86 staff members and visiting 6 hospitals.Results.The survey response rate was 72%; 83% of hospitals reported using semirecumbent positioning, and only 21% reported using subglottic secretion drainage. Multivariable analyses indicated collaborative initiatives were associated with the use of semirecumbent positioning but provided little guidance regarding the use of subglottic secretion drainage. Qualitative analysis, however, revealed 3 themes: (1) collaboratives strongly influence the use of semirecumbent positioning but have little effect on the use of subglottic secretion drainage; (2) nurses play a major role in the use of semirecumbent positioning, but they are only minimally involved with the use of subglottic secretion drainage; and (3) there is considerable debate about the evidence supporting subglottic secretion drainage, despite a meta-analysis of 5 randomized trials of subglottic secretion drainage that generally supported this preventive practice, compared with only 2 published randomized trials of semirecumbent positioning, one of which concluded that it was ineffective at preventing the development of VAP.Conclusion.Semirecumbent positioning is commonly used to prevent VAP, whereas subglottic secretion drainage is used far less often. We need to understand better how evidence related to prevention practices is identified, interpreted, and used to ensure that research findings are reliably translated into clinical practice.

2020 ◽  
Vol 29 (155) ◽  
pp. 190107 ◽  
Author(s):  
Diana P. Pozuelo-Carrascosa ◽  
Ángel Herráiz-Adillo ◽  
Celia Alvarez-Bueno ◽  
Jose Manuel Añón ◽  
Vicente Martínez-Vizcaíno ◽  
...  

Although several guidelines recommend subglottic secretion drainage as a strategy for prevention of ventilator-associated pneumonia (VAP), its use is not widespread. With the aim to assess the effectiveness of subglottic secretion drainage for preventing VAP and to improve other outcomes such as mortality, duration of mechanical ventilation and length of stay in the intensive care unit (ICU) or hospital, an electronic search of the Cochrane Library, MEDLINE, Web of Science and Embase was undertaken. Nine systematic reviews with meta-analysis (in the overview of reviews) and 20 randomised controlled trials (in the updated meta-analysis) were included.In the overview of reviews, all systematic reviews with meta-analysis included found a positive effect of subglottic secretion drainage in the reduction of incidence of VAP. In the updated meta-analysis, subglottic secretion drainage significantly reduced VAP incidence (risk ratio (RR) 0.56, 95% CI 0.48–0.63; I2=0%, p=0.841) and mortality (RR 0.88, 95% CI 0.80–0.97; I2=0%, p=0.888).This is the first study that has found a decrease of mortality associated with the use of subglottic secretion drainage. In addition, subglottic secretion drainage is an effective measure to reduce VAP incidence, despite not improving the duration of mechanical ventilation and ICU and/or hospital length of stay.


2011 ◽  
Vol 39 (8) ◽  
pp. 1985-1991 ◽  
Author(s):  
John Muscedere ◽  
Oleksa Rewa ◽  
Kyle Mckechnie ◽  
Xuran Jiang ◽  
Denny Laporta ◽  
...  

2005 ◽  
Vol 118 (1) ◽  
pp. 11-18 ◽  
Author(s):  
Cameron Dezfulian ◽  
Kaveh Shojania ◽  
Harold R. Collard ◽  
H. Myra Kim ◽  
Michael A. Matthay ◽  
...  

2013 ◽  
Vol 26 (4) ◽  
pp. 180-188 ◽  
Author(s):  
Steven A. Frost ◽  
Azmeen Azeem ◽  
Evan Alexandrou ◽  
Victor Tam ◽  
Jeffrey K. Murphy ◽  
...  

2015 ◽  
Vol 2 (2-3) ◽  
pp. 55-60 ◽  
Author(s):  
Rong Wang ◽  
Xiang Zhen ◽  
Bao-Yi Yang ◽  
Xue-Zhen Guo ◽  
Xue Zeng ◽  
...  

2020 ◽  
Vol 41 (S1) ◽  
pp. s259-s260
Author(s):  
Rafaela Pinho ◽  
Luciana Tanure ◽  
Jussara Pessoa ◽  
Leonardo Santos ◽  
Braulio Couto ◽  
...  

Background: Ventilator-associated lower respiratory infections (LRIs) and pneumonia (VAP) are important healthcare-associated infections and are among the leading causes of death worldwide. Prevention of these infections are often based on care bundles. We investigated the incidence of VAP+LRI and the preventive efficacy of each component of our ventilator bundle. Methods: Our ventilator bundle includes 6 components that are daily checked by an infection control practitioner. These 6 evidence-based practices were implemented in 3 ICUs from a general tertiary-care private hospital in Belo Horizonte City (Brazil): (1) daily oral care with chlorhexidine; (2) elevate the head of the bed to between 30 and 45; (3) avoid scheduled ventilator circuit change; (4) monitor cuff pressure; (5) use subglottic secretion drainage; and (6) daily sedation interruption and daily assessment of readiness to extubate. VAP and ventilator-LRI definitions were obtained from the CDC NHSN. The impact of adherence rate to items in the ventilator bundle (%) on the incidence rate of VAP+LRI was assessed using linear regression and scatterplot analyses. Results: Between January 2018 and April 2019, 1,888 ventilator days were observed in the 3 ICUs, with 42 VAP and LRI events, an overall incidence rate of 22.2 cases per 1,000 ventilator days. After September 2018, the infection control service started a campaign to increase the ventilator bundle compliance (Fig. 1). Adherence rates to all 6 bundle components increased between January–August 2018 and September 2018–April 2019 from 25% to 55% for daily oral care, from 34% to 79% for elevating the head of the bed, 28% to 86% for avoiding scheduled ventilator circuit change, from 32% to 83% for cuff pressure monitoring, from 32% to 83% for subglottic secretion drainage, and from 33% to 85% for daily sedation interruption. PAV and LRI incidence decreased from 41 to 16 in ICU A, from 22 to 14 in ICU B and from 24 to 18 in ICU C. The impact of each bundle component was identified by linear regression, calculating the percentage of PAV+LRI incidence rate that is explained by bundle item adherence (r2) and correlation coefficient (r): daily sedation interruption (r2 = 48%; r = 0.69; P = .004) (Fig. 2), cuff pressure monitorization (r2 = 0.3721; r = 0.61; P = .016), subglottic secretion drainage (r2 = 36%; r = 0.60; P = .017), avoidance of scheduled ventilator circuit change (r2 = 34%; r = 0.58; P = .023), daily oral care (r2 = 25%; r = 0.50; P = .050), and elevate the head of the bed (r2 = 25%; r = 0.48; P = .067). Conclusions: The impact of each bundle component on preventing PAV+LRI was identified by the study. An educational intervention performed by the infection control service increased the adherence to the ventilator bundle, and the PAV and LRI incidence decreased.Funding: NoneDisclosures: None


2021 ◽  
Vol 9 (4) ◽  
pp. 506-511
Author(s):  
  Md. Zubyeer Ali Sheikh ◽  
A. K. Qumrul Huda ◽  
Montosh Kumar Mondal ◽  
Md. Mohiuddin Majed Chy ◽  
Mohammad Mahbubuzzaman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document